يعرض 1 - 10 نتائج من 310 نتيجة بحث عن '"Hansson, Markus"', وقت الاستعلام: 1.03s تنقيح النتائج
  1. 1
    كتاب

    المساهمون: HUS Comprehensive Cancer Center, Department of Clinical Chemistry and Hematology, Hematologian yksikkö

    مصطلحات موضوعية: 3122 Cancers

    وصف الملف: application/pdf

    العلاقة: Supported by the European Union’s Horizon 2020 research and innovation program, grant No 856620 and the SALVAGE project, reg.no: CZ.02.01.01/00/22_008/0004644.; Hemminki , K , Zitricky , F , Försti , A , Silvennoinen , R , Vangsted , A & Hansson , M 2024 , ' Large differencies in age-specific survival in multiple myeloma in the nordic countries ' , Blood cancer journal , vol. 14 , no. 1 , 43 . https://doi.org/10.1038/s41408-024-01026-6Test; http://hdl.handle.net/10138/573666Test; d087800b-89fa-4ece-9511-a1437d3d52a6; 85187438635; 001182485900001

  2. 2
    دورية أكاديمية

    المساهمون: HUS Comprehensive Cancer Center, Hematologian yksikkö

    وصف الملف: application/pdf

    العلاقة: This study was funded by Takeda Pharmaceuticals International AG , who contributed to the study concept/design, protocol analysis and interpretation of results. Writing support was provided by Parexel, funded by Takeda Pharmaceutical Company Ltd .; Abildgaard , N , Anttila , P , Waage , A , Rubin , K H , Ørstavik , S , Bent-Ennakhil , N , Gavini , F , Ma , Y , Freilich , J & Hansson , M 2024 , ' Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden : An analysis using linked Nordic registries ' , European Journal of Cancer , vol. 201 , 113921 . https://doi.org/10.1016/j.ejca.2024.113921Test; http://hdl.handle.net/10138/574828Test; ac4eecb9-dcdf-4116-b390-9d9019a7fcad; 85186262023; 001199901300001

  3. 3
    دورية أكاديمية

    المصدر: Nielsen , L K , Schjesvold , F , Möller , S , Guldbrandsen , N , Hansson , M , Remes , K , Peceliunas , V , Abildgaard , N , Gregersen , H & King , M T 2024 , ' Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma : a randomized phase 2 trial by the Nordic Myeloma Study Group ' , Journal of Patient-Reported Outcomes , vol. 8 , no. 1 , 15 . https://doi.org/10.1186/s41687-024-00691-2Test

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المصدر: Nielsen , L K , Schjesvold , F , Möller , S , Guldbrandsen , N , Hansson , M , Remes , K , Peceliunas , V , Abildgaard , N , Gregersen , H & King , M T 2024 , ' Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma : a randomized phase 2 trial by the Nordic Myeloma Study Group ' , Journal of patient-reported outcomes , vol. 8 , 15 . https://doi.org/10.1186/s41687-024-00691-2Test

    وصف الملف: application/pdf

  7. 7
    دورية أكاديمية

    المصدر: Nielsen , L K , Schjesvold , F , Möller , S , Guldbrandsen , N , Hansson , M , Remes , K , Peceliunas , V , Abildgaard , N , Gregersen , H & King , M T 2024 , ' Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group ' , Journal of Patient-Reported Outcomes , vol. 8 , no. 1 , 15 . https://doi.org/10.1186/s41687-024-00691-2Test

    وصف الملف: application/pdf

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المساهمون: Knut och Alice Wallenbergs Stiftelse, Swedish Cancer Foundation, Region Skåne

    المصدر: European Journal of Haematology ; volume 113, issue 1, page 72-81 ; ISSN 0902-4441 1600-0609